Simuni et al., reported a weak correlation between MDS-UPDRS-III and dopamine transporter binding in Parkinson’s Progression Markers Initiative (PPMI) cohort at the baseline with a Spearman correlation coefficient of −0.2119 for the contralateral putamen specific binding ratio [7]. Here, SLC6A3 is linked to Parkinson disease.